Journal article

Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.

Jing Lou, Sarin Kc, Kai Yee Toh, Saudamini Dabak, Amanda Adler, Jeonghoon Ahn, Diana Beatriz S Bayani, Kelvin Chan, Dechen Choiphel, Brandon Chua, Anne Julienne Genuino, Anna Melissa Guerrero, Brendon Kearney, Lydia Wenxin Lin, Yuehua Liu, Ryota Nakamura, Fiona Pearce, Shankar Prinja, Raoh-Fang Pwu, Asrul Akmal Shafie Show all

Int J Technol Assess Health Care | Published : 2020


There is growing interest globally in using real-world data (RWD) and real-world evidence (RWE) for health technology assessment (HTA). Optimal collection, analysis, and use of RWD/RWE to inform HTA requires a conceptual framework to standardize processes and ensure consistency. However, such framework is currently lacking in Asia, a region that is likely to benefit from RWD/RWE for at least two reasons. First, there is often limited Asian representation in clinical trials unless specifically conducted in Asian populations, and RWD may help to fill the evidence gap. Second, in a few Asian health systems, reimbursement decisions are not made at market entry; thus, allowing RWD/RWE to be colle..

View full abstract